Cargando…

Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study

OBJECTIVE: Risk models and scores have been developed to predict incidence of type 2 diabetes in Western populations, but their performance may differ when applied to non-Western populations. We developed and validated a risk score for predicting 3-year incidence of type 2 diabetes in a Japanese pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanri, Akiko, Nakagawa, Tohru, Kuwahara, Keisuke, Yamamoto, Shuichiro, Honda, Toru, Okazaki, Hiroko, Uehara, Akihiko, Yamamoto, Makoto, Miyamoto, Toshiaki, Kochi, Takeshi, Eguchi, Masafumi, Murakami, Taizo, Shimizu, Chii, Shimizu, Makiko, Tomita, Kentaro, Nagahama, Satsue, Imai, Teppei, Nishihara, Akiko, Sasaki, Naoko, Hori, Ai, Sakamoto, Nobuaki, Nishiura, Chihiro, Totsuzaki, Takafumi, Kato, Noritada, Fukasawa, Kenji, Huanhuan, Hu, Akter, Shamima, Kurotani, Kayo, Kabe, Isamu, Mizoue, Tetsuya, Sone, Tomofumi, Dohi, Seitaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641714/
https://www.ncbi.nlm.nih.gov/pubmed/26558900
http://dx.doi.org/10.1371/journal.pone.0142779
Descripción
Sumario:OBJECTIVE: Risk models and scores have been developed to predict incidence of type 2 diabetes in Western populations, but their performance may differ when applied to non-Western populations. We developed and validated a risk score for predicting 3-year incidence of type 2 diabetes in a Japanese population. METHODS: Participants were 37,416 men and women, aged 30 or older, who received periodic health checkup in 2008–2009 in eight companies. Diabetes was defined as fasting plasma glucose (FPG) ≥126 mg/dl, random plasma glucose ≥200 mg/dl, glycated hemoglobin (HbA1c) ≥6.5%, or receiving medical treatment for diabetes. Risk scores on non-invasive and invasive models including FPG and HbA1c were developed using logistic regression in a derivation cohort and validated in the remaining cohort. RESULTS: The area under the curve (AUC) for the non-invasive model including age, sex, body mass index, waist circumference, hypertension, and smoking status was 0.717 (95% CI, 0.703–0.731). In the invasive model in which both FPG and HbA1c were added to the non-invasive model, AUC was increased to 0.893 (95% CI, 0.883–0.902). When the risk scores were applied to the validation cohort, AUCs (95% CI) for the non-invasive and invasive model were 0.734 (0.715–0.753) and 0.882 (0.868–0.895), respectively. Participants with a non-invasive score of ≥15 and invasive score of ≥19 were projected to have >20% and >50% risk, respectively, of developing type 2 diabetes within 3 years. CONCLUSIONS: The simple risk score of the non-invasive model might be useful for predicting incident type 2 diabetes, and its predictive performance may be markedly improved by incorporating FPG and HbA1c.